jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
Journal of Young PharmacistsNOW IN
Review

Therapeutic and Dermatological Potential of Ganoderma lucidum (Reishi/Lingzhi) in Cosmeceutical Formulations: A Comprehensive Review

Pankaj Sharma1★★ Corresponding author

  1. 1Department of Pharmaceutics, Government College of Pharmacy, Rohru, Shimla, Himachal Pradesh, INDIA.

CORRESPONDENCE

Pankaj Sharma

Assistant Professor (Pharmacy), Department of Pharmaceutics, Government College of Pharmacy, Rohru, Shimla-171207, Himachal Pradesh, INDIA.

pankajsharmadrugs@gmail.com

ORCID: 0000-0001-7640-5766

Received: 22-05-2026; Revised: 13-07-2026; Accepted: 07-08-2026.

Volume 18, Issue 3 · pp. 646–655 · PUBLISHED Jul-Sep 2026 · DOI: 10.5530/jyp.20260426

View on JYP original site ↗

ABSTRACT

Ganoderma lucidum (Reishi) is a widely utilized medicinal mushroom in Asia, recognized for its hepatoprotective, antioxidant, immunomodulatory, and anticancer properties. The present review aims to systematically evaluate its cosmeceutical potential by examining bioactive composition, mechanistic dermatological effects, formulation strategies, and translational challenges. A comprehensive analysis of published in vitro, in vivo, and emerging clinical evidence was conducted, focusing on phytochemical constituents and advanced delivery approaches relevant to dermal applications. Key bioactive compounds including triterpenoids, polysaccharides, phenolics, sterols, peptides, and UV-enhanced Vitamin D₂ demonstrate significant antioxidant, anti-inflammatory, anti-melanogenic, and skin-regenerative activities. Triterpenes and phenolics contribute to oxidative stress reduction and pigmentation control, supporting anti-aging and melanin disorder management. Polysaccharides enhance skin hydration, barrier integrity, and wound healing, while Vitamin D₂ promotes photoprotection and epidermal renewal. Recent advances in green extraction technologies and nanocarrier-based delivery systems (e.g., lipid nanoparticles and nanoformulations) have improved bioactive stability, dermal penetration, and controlled release, thereby strengthening formulation performance. Despite promising preclinical evidence, limitations persist, including insufficient large-scale clinical validation, variability in phytochemical standardization, and regulatory constraints affecting commercialization. Addressing these gaps through harmonized quality control, robust clinical trials, and optimized delivery systems is essential for global acceptance. Overall, G. lucidum emerges as a scientifically grounded and sustainable candidate for next-generation cosmeceutical development, aligning with increasing consumer demand for safe, effective, and environmentally responsible dermocosmetic innovations.

KEYWORDS

0% READ

FULL TEXT

INTRODUCTION

The cosmeceuticals industry represents a dynamic convergence of cosmetics and pharmaceuticals, integrating bioactive compounds with demonstrated pharmacological activity to enhance both skin health and aesthetic outcomes (Gao et al., 2003). Unlike conventional cosmetics that primarily address superficial appearance, cosmeceuticals provide therapeutic benefits supported by mechanistic evidence. Increasing consumer demand for safe, effective, and sustainably sourced ingredients has accelerated the exploration of natural bioactives, particularly fungi, plant extracts, and marine-derived compounds recognized for their antioxidant, anti-inflammatory, antimicrobial, and photoprotective properties (Wasser, 2002; Lin, 2005). These biological activities are essential for mitigating oxidative stress, preventing premature skin aging, preserving dermal extracellular matrix integrity, and promoting tissue repair. Among medicinal fungi, Ganoderma lucidum holds particular significance. Traditionally revered in Traditional Chinese Medicine (TCM) as a symbol of longevity and vitality, it has gained substantial global scientific attention for its dermatological potential (Boh et al., 2007). Its diverse secondary metabolites- including triterpenoids, polysaccharides, phenolic acids, and steroids exhibit immunomodulatory, antioxidant, anti-inflammatory, and skin-regenerative activities, providing a strong mechanistic rationale for its incorporation into cosmeceutical formulations (Bishop et al., 2015). Despite increasing commercialization of mushroom-based skincare products, systematic scientific evaluation of G. lucidum in cosmeceuticals remains limited. Therefore, this review critically examines its phytochemical composition, biological activities, and dermal mechanisms relevant to skin health. Furthermore, it discusses formulation strategies, current industrial applications, and challenges related to standardization, stability, and regulatory compliance, thereby positioning G. lucidum as a promising and scientifically substantiated cosmeceutical ingredient.

Overview of G. lucidum

G. lucidum is a Basidiomycota mushroom (order Polyporales, family Ganodermataceae) that grows on decaying hardwoods such as oak and maple. It is identified by its hard, woody texture and kidney-shaped, reddish-brown varnished cap. Considered a benchmark species within its genus, it contains diverse secondary metabolites including triterpenoids, polysaccharides, sterols, and peptides responsible for its therapeutic and cosmeceutical relevance (Xu et al., 2019). Revered for over 4,000 years in Eastern medicine as the “mushroom of immortality,” its classification follows the standard taxonomic hierarchy from kingdom to species (Figure 1).

Figure 1: Shows the taxonomical and botanical description of G. lucidum.

Morphological Characters of G. lucidum

G. lucidum is a member of the fungus family Ganodermataceae. In addition to its therapeutic purpose, its morphology is described by particular traits and developmental stages that define its life cycle.

Phase One

Mycelium - When G. lucidum produces a white mycelial network made up of tiny, anastomosable branches known as hyphae, vegetative activity begins. As they spread across the woody substrate (logs, stumps, or sawdust), these filamentous threads take up nutrients and lay the groundwork for the growth of fruiting bodies. In G. lucidum, mycelium plays a crucial role in the formation of polysaccharides and triterpenoids through submerged or solid-state fermentation (Thakur et al., 2015).

Second Phase

Primordia (Fruiting Initiation) - Primordia are tiny nodular outgrowths that appear on the substrate when nutrients are properly assimilated. These indicate the start of the fruiting body. Primordia elongate and differentiate into fruiting bodies when the humidity, temperature, and aeration are all conducive (Sudheer and Gangaprasad, 2017).

Phase Three

Basidiocarp (Fruiting Body/Equivalent to Stroma) - The kidney-shaped to semicircular basidiocarp with a reddish-brown varnished and glossy covering is the most noticeable and culturally acceptable type. It has a rough feel, similar to wood, and can reach a diameter of several centimeters. It is commonly collected for medicinal purposes in extracts, decoctions, and contemporary cosmeceutical formulations (Yue et al., 2008).

Fourth Phase

Basidiospores - Instead of gills, its underside is composed of tiny pores where basidia grow and create basidiospores. The sexual reproductive units of G. lucidum are called basidiospores. After being released into the environment, they germinate under the right conditions, develop into new hyphae, and initiate a new stage of the fungus' life cycle (Akihisa et al., 2007).

Additional Feature

Lucidum Varnished Surface - The formation of pigment and secondary metabolites, especially triterpenoids, gives G. lucidum its glossy, lacquered appearance, which is another characteristic that sets it apart. It contributes to its medicinal character and distinguishes it morphologically from some other Ganoderma species.

Therefore, G. lucidum morphological stages such as mycelial colonization that results in a traditional varnished woody fruiting body with an abundance of bioactive compounds, G. lucidum has cosmeceutical value.

Profile of phytochemicals

The main source of G. lucidum's bioactivity is its wide range of secondary metabolites, some of which have been thoroughly studied and linked to both pharmacological and cosmetic effects.

Major classes of compounds

Polysaccharides

The majority of polysaccharides are β-glucans, which have immunomodulatory, moisturizing, and wound-healing properties. For an anti-aging impact, these high molecular weight compounds increase collagen synthesis and improve the skin's barrier function (Shiao, 2003).

Triterpenoids

A broad class of compounds with anti-inflammatory, anti-allergic, antioxidant, and anti-proliferative properties that includes lucidenic and ganoderic acids. These chemicals are crucial for protecting the dermis from external assaults and early aging because of their capacity to modulate oxidative stress pathways (Baby and Johnson, 2017).

Sterols

Its primary sterol, ergosterol, possesses special cosmeceutical interest since it can photoconvert into vitamin D₂ upon exposure to light, besides providing photoprotection (Zhang et al., 2019).

Phenolic compounds

G. lucidum is rich in a multitude of phenolic acids with strong antioxidant and protective activities. Protocatechuic acid, p-hydroxybenzoic acid, and caffeic acid are illustrative examples. Such phenolic compounds impart G. lucidum cosmeceutical value as it can preserve dermal health, enhance medicinal potential, and avoid oxidative stress.

These molecules collectively provide antioxidant, anti-inflammatory, whitening, barrier-repair, and environmental protective effects, supporting their incorporation into innovative cosmeceutical formulations.

Characterization of G. lucidum

Phytochemical profiling of G. lucidum employs advanced analytical techniques for precise bioactive characterization. High-Performance Liquid Chromatography (HPLC) quantifies triterpenoids and phenolics, while LC-MS/MS enables sensitive detection and structural elucidation of primary and secondary metabolites at trace levels. Nuclear Magnetic Resonance (NMR) spectroscopy further supports comprehensive structural analysis of complex triterpenoids, sterols, and polysaccharides.

Mechanisms of Action in Skin Health

G. lucidum exhibits multilayered dermo modulatory effects via polysaccharides, triterpenoids, phenolic acids, and ergosterol derivatives. These bioactives regulate oxidative stress, inflammation, barrier integrity, pigmentation, and skin regeneration, supporting its strong potential in cosmeceutical and dermatotherapeutic formulations (Hsu et al., 2020).

Antioxidant Activity

Reactive Oxygen Species (ROS), which are produced in reaction to UV irradiation and environmental contaminants, cause accelerated oxidative stress that significantly accelerates skin aging. Triterpenoids and phenolic chemicals found in G. lucidum are strong radical scavengers that reduce lipid peroxidation and stop DNA fragmentation in fibroblasts and keratinocytes. Photoaging and wrinkle development are postponed by this antioxidant defense (Yuen and Gohel, 2005).

Anti-inflammatory Activity

Prolonged inflammation leads to extrinsic aging, dermatitis, and acne. G. lucidum inhibits Nuclear Factor-Kappa B (NF-κB) signaling, which lowers the expression of inflammatory enzymes like COX-2 and iNOS as well as pro-inflammatory cytokines like TNF-α and IL-6. As a result, cutaneous inflammatory tissues experience reduced erythema, inflammation, and edema (Joseph et al., 2011).

Moisturization and Barrier Restoration

Polysaccharides increase skin moisture and chelate hydrated molecules to exhibit their hygroscopic activity. Additionally, polysaccharides promote the production of ceramides, which restores the function of the stratum corneum barrier. This makes G. lucidum a potential cause of atopic disorders and xerosis (Kim et al., 2012).

Wound Healing and Regeneration

Polysaccharides and triterpenoids promote collagen deposition, increase fibroblast proliferation, and upregulate Transforming Growth Factor-beta (TGF-β), all of which lead to improved tissue regeneration and increased wound contraction. Anti-aging and post-acne scar treatment benefit from this regenerative action (Xu et al., 2010).

Whitening and Anti-Pigmentation

Triterpenoids and phenolic acids, which are tyrosinase inhibitors, work on the primary melanogenesis enzyme to reduce melanin manufacture and suppress hyperpigmentation. This results in whitening and anti-pigmentation. These work effectively for skin whitening procedures, cosmetic whitening products, and evening out the complexion (Wasser, 2014).

UV Protection and Vitamin D₂ Modulation

When G. lucidum is exposed to UV-B light, its ergosterol is photoconverted to Vitamin D₂. Vitamin D₂ improves cutaneous immunity, reduces photodamage, and encourages keratinocyte differentiation when applied topically. Both protection and nutritional support for the skin are provided by this dual action (Table 1).

Table 1: Phytochemical of G. lucidum and Their Reported Skin-Related Bioactivities.
Phytochemical groupRepresentative compoundsSkin-related bioactivitiesAnalytical methodsReferences
TriterpenoidsGanoderic acids, Lucidenic acidsAnti-inflammatory, anti-aging, antioxidant, skin brighteningHPLC, LC-MS, NMR(Wasser, 2010)
Polysaccharidesβ-glucans, heteropolysaccharidesMoisturizing, barrier repair, wound healing, collagen promotionGC-MS, HPSEC, NMR(Baby et al., 2019)
SterolsErgosterolPhotoprotective (Vitamin D₂ precursor), skin healthHPLC, UV spectrophotometry, NMR(Zhang et al., 2019; Chen et al., 2012)
Peptides and proteinsFungal Immunomodulatory Proteins (FIPs), antioxidant peptidesAntioxidant, moisturizing, protectiveLC-MS, SDS-PAGE, NMR(Paterson and Lima, 2014)
PhenolicsCaffeic acid, p-hydroxybenzoic acid, Protocatechuic acidAntioxidant, anti-inflammatory, photoprotectionHPLC, LC-MS/MS(Chan et al., 2007)

Pharmaceutical and Cosmetic Applications

G. lucidum bioactives are increasingly incorporated into pharmaceutical and cosmetic formulations for immunomodulatory, moisturizing, whitening, anti-inflammatory, antioxidant, and UV-protective effects, highlighting its broad dermocosmetic potential (Figure 1).

To further highlight their composition and functional role, various dosage forms have been systematically summarized in Table 2.

Table 2: Representative pharmaceutical and cosmetic formulations of G. lucidum and their associated benefits.
Formulation TypeBenefitActive Ingredient(s)References
Pharmaceuticals
Supplements (Syrup)Support immune system functionPolysaccharides, triterpenoids(Sanodiya et al., 2009)
CapsulesGeneral health promotion, antioxidantStandardized extracts(Lin et al., 2003)
Spore powderEnhance vitality, immune regulationSpore-derived bioactive fractions(Guo et al., 2019)
Cosmetic Formulations
Cream/LotionMoisturizing, soothingTriterpenoid-rich fractions(Yue et al., 2013)
Liquid CleanserDeep cleansing, detoxifyingPolysaccharide-enriched extracts(Yue et al., 2013)
Face MaskBrightening, hydrationGanoderma polysaccharide gel(Yue et al., 2013)
Moisturizing CreamLong-lasting hydration, barrier repairPolysaccharide-peptide complexes(Yue et al., 2013)
TonerPore tightening, anti-acneAlcoholic extract enriched with anti-inflammatory agents(Yue et al., 2013)
Sunscreen AdditiveUV protection, Vitamin D enhancementErgosterol-enriched fractions(Yue et al., 2013)
SerumAnti-aging, antioxidantUV-treated Ganoderma extract (Vitamin D₂ enriched)(Yue et al., 2013)

G. lucidum modulates melanogenesis, inflammation, oxidative stress, and hydration, bridging therapeutic and cosmetic skincare applications.

Scientific Evidence Supporting Cosmetic Use

A growing body of in vitro, ex vivo, and in vivo research supports G. lucidum for cosmetic use, demonstrating anti-aging, anti-inflammatory, and antioxidant mechanisms, with clinical and consumer studies confirming its safety and dermatological efficacy (Figure 2).

Figure 2: Showing the distinct structures and developmental phases.

In vitro/Ex vivo Evidence

G. lucidum demonstrates strong antioxidant, anti-inflammatory, and collagen-protective effects in in vitro and ex vivo studies, supporting its potential for skin rejuvenation and regeneration. However, further clinical validation is required for confirmed cosmetic applications (Table 3).

Table 3: Showing the in vitro/Ex vivo Evidence of G. lucidum.
Study modelIntervention (G. lucidum form)Primary cosmetic-relevant outcomesKey notesReferences
Enzymatic/chemical assays (DPPH, FRAP, tyrosinase)Ethanolic/aqueous extracts from multiple G. lucidum varietiesStrong radical scavenging (DPPH/FRAP) and tyrosinase inhibition; activity correlated with polyphenol content.Recent macrofungal survey includes G. lucidum among top performers(Liu et al., 2022)
Mycelial culture extractsAntioxidant and anti-tyrosinase screeningAntioxidant activity and tyrosinase inhibition confirmed for cultured mycelium fractions.Supports scalable cosmetic sourcing from mycelium(Sliva et al., 2002)
Human Dermal Fibroblasts (HDFs)Polysaccharide-rich extracts (GL-PS)Protection from UVB-induced photoaging, reduced ROS, preserved collagen.Mechanistic evidence for anti-photoaging(Zhao et al., 2019)
Human Dermal Fibroblasts (HDFs)Polysaccharide-rich extract (aqueous)↑ Proliferation and migration, ↑ collagen synthesis.Direct pro-regenerative signal for wound/anti-aging claims(Chien et al., 2004)
Human keratinocytes and fibroblastsEthanol extractAntioxidant cytoprotection, pro-migration, modulation of MMP-2/9 and stress kinases (AKT/ERK/p53/p21).Supports re-epithelialization and anti-oxidative defense(Yeh et al., 2009)
Pigmentation models (cell-based and zebrafish)GL-polysaccharides / phenolic-rich fractionsAnti-melanogenic effects; tyrosinase pathway modulation.Multiple datasets indicate whitening potential(Hapuarachchi et al., 2018)

In vivo/Clinical and Consumer-Use Evidence

There is little clinical data on G. lucidum's topical use; consumer research and small-scale trials have indicated good tolerance and some skin benefits, but thorough randomized controlled trials are still required to verify safety and efficacy summarized in Table 4.

Table 4: Showing the in vivo/Clinical and Consumer-Use Evidence.
Population / designFormulationOutcomesKey NotesReferences
Narrative/umbrella reviews of clinical and cosmetic applicationsVarious cosmetic products containing G. lucidum extractsReports of improved brightness and reduced pigmentation, supportive of cosmeceutical positioning.Secondary evidence synthesizing small studies and product data; calls for RCTs(Zhu et al., 2007)
Dermatocosmetic safety/cosmetic properties review (mushroom extracts)Multiple macrofungi including G. lucidumGood tolerability profiles cited; antioxidant/whitening mechanisms summarized.Human safety within cosmetic use discussed; not an RCT(Bao et al., 2001)
Topical potential (review)G. lucidum extracts as bioactive in topical formulationsSupports anti-aging/whitening rationale; highlights formulation strategies.Methodological guidance; urges clinical validation(Xu et al., 2011)
Combination cosmetic extract study (includes G. lucidum)Multi-botanical formula stability and efficacy endpointsExplores stability/efficacy; not G. lucidum monotherapy.Useful for real-world product context; limited attribution(Jiang et al., 2008)

Patents

Recent filings and grants of new patents in G. lucidum research demonstrate the plant's many uses. According to Table 4, the authorities have also granted other patents, which are anticipated to increase demand for G. lucidum as a promising natural cosmeceutical agent with extensive potential in the pharmaceutical, medical, and personal care sectors summarized in Table 5.

Table 5: Showing the patent in recent year.
Sl. No.Patent titlePatent / Grant numberInventor(s)Grant / Publication DateCountry
1Eco-friendly extraction of G. lucidum using aqueous cyclodextrin solution.US11,433,019B2Amorepacific Corp. inventors06.09.2022USA
2Cosmetic composition comprising G. lucidum extract for anti-aging.US2020/0253859A1Amorepacific Corp. inventors13.08.2020USA
3Cosmetic composition for skin whitening comprising ganodermanondiol from G. lucidum mycelia.KR10-2013-0050751Korean inventors (Han et al.)08.05.2013Republic of Korea
4Novel G. lucidum strains (M2-100-02, M2-102-02) with high ganoderic acid and β-glucan yield.US2024/0349663A1Korean inventors (Choi et al.)31.10.2024USA
5G. lucidum polysaccharide GLP-2 for reducing cisplatin toxicity and treating cancer.US2025/0134922A1Chinese inventors01.05.2025USA
6Extraction and preparation method of G. lucidum polysaccharide GLP-3.US2025/0144130A1Chinese inventors08.05.2025USA
7Mutant recombinant G. lucidum immunomodulatory protein.US2023/0212233A1Taiwanese inventors06.07.2023USA
8Biologically active compounds from G. lucidum (ergosterol peroxide derivatives) for anticancer use.PCT/US2020/017053Revive Therapeutics inventors13.02.2020International (PCT)

Comparative Value with Other Medicinal Mushroom

The bioactive compounds found in medicinal mushrooms are abundant and have important cosmeceutical applications. Each of these compounds has its own mechanisms that support skin health and anti-aging benefits (Figure 3). Most notably, Cordyceps sinensis is known for its anti-aging peptides, which support cellular viability, skin regeneration, and the prevention of dermal senescence. β-glucans, which are plentiful in Trametes versicolor, have immune-modulatory actions and protect the integrity of the epidermal barrier. Pleurotus species are characterized by the presence of antioxidant chemicals that reduce oxidative stress and guard against photodamage. Polysaccharides, triterpenoids, and peptides are only a few of the many bioactive compounds found in G. lucidum that have strong cosmeceutical potential. Numerous patents and new product advancements support its uses in dermatological formulations, anti-aging, and skin rejuvenation summarized in Table 6.

Figure 3: Showing the phytochemical constituents.
Table 6: Comparative cosmeceutical potential of major medicinal mushrooms.
Sl. No.Mushroom SpeciesKey Bioactive CompoundsCosmeceutical RelevanceReferences
1Cordyceps sinensisAnti-aging peptidesSupports skin regeneration, cellular vitality(Xu et al., 2011)
2Trametes versicolorβ-GlucansImmune modulation, skin barrier support(Bishop et al., 2015)
3Pleurotus spp.Antioxidant compoundsReduces oxidative stress, protects against photodamage(Zhu et al., 2006)
4Ganoderma lucidumPolysaccharides, triterpenoids, peptidesBroad-spectrum bioactivity, anti-aging, dermatological applications, cosmeceutical patents(Tang et al., 2006)

Challenges and Research Gaps

Despite its rich bioactive profile, G. lucidum faces significant translational challenges in cosmeceutical applications. Variability in strains, substrates, and cultivation conditions leads to inconsistent levels of polysaccharides, triterpenoids, and ergosterol, complicating standardization, extraction reproducibility, and quality control. Ergosterol-derived Vitamin D₂ is thermolabile and prone to photodegradation and oxidative instability, while triterpenoids exhibit limited dermal bioavailability. Advanced delivery systems, including solid lipid nanoparticles, liposomes, and nanogels, are under investigation to enhance stability and skin permeation. Regulatory constraints, particularly in the US and EU, stem from insufficient human clinical evidence supporting anti-aging, anti-inflammatory, and depigmenting claims. Additionally, limited data on excipient-extract interactions restrict formulation optimization, underscoring the need for rigorous clinical validation and mechanistic studies (Figure 4).

Figure 4: Showing the Mechanisms of Action in Skin Health G. lucidum.

Future Prospectives

Future research on G. lucidum emphasizes advanced formulation and sustainable production strategies to address current limitations. Omics-driven approaches, including proteomics and metabolomics, support extract standardization and identification of novel bioactives. Smart delivery systems liposomes, nanoemulsions, solid lipid nanoparticles, microneedles, and transdermal patches are being developed to enhance vitamin D₂ stability, dermal penetration, and controlled release for conditions such as psoriasis, eczema, and photodamage. Polysaccharide-based films demonstrate potential for sustained release and improved therapeutic efficacy. Synergistic formulations combining G. lucidum with retinoids, peptides, hyaluronic acid, niacinamide, and botanical antioxidants may amplify anti-aging benefits, including hydration and elasticity. Prebiotic polysaccharides also support microbiome-friendly skincare. Sustainable cultivation using agro-waste substrates and green extraction technologies, such as enzyme-assisted and supercritical CO₂ methods, promotes eco-friendly production, while regulatory harmonization and clinical validation remain essential for global commercialization and consumer confidence (Figure 5).

Figure 5: Representative pharmaceutical and cosmetic formulations of G. lucidum and their associated health/skin benefits.

CONCLUSION

G. lucidum has emerged as a versatile and scientifically promising bio-resource in cosmeceutical research due to its diverse bioactive constituents, including polysaccharides, triterpenoids, phenolic compounds, and peptides. These metabolites collectively exert antioxidant, anti-inflammatory, anti-melanogenic, and collagen-protective effects, supporting skin rejuvenation, barrier integrity, and photoprotection. UV-enhanced Vitamin D₂ further strengthens its dermatological relevance, reinforcing its multifunctional role in skin health management. Advances in green extraction technologies and nanocarrier-based delivery systems have improved stability, dermal penetration, and formulation performance, enhancing its translational potential. However, significant challenges remain, including variability in phytochemical standardization, limited large-scale clinical validation, and evolving regulatory frameworks. Future research should prioritize harmonized quality control protocols, well-designed randomized clinical trials, mechanistic pathway elucidation using omics technologies, and optimization of smart delivery systems for targeted and sustained release. Sustainable cultivation practices and life-cycle assessments should also be integrated to ensure eco-friendly commercialization. Interdisciplinary collaboration among mycologists, dermatologists, formulation scientists, and regulatory authorities will be essential to transform G. lucidum from a promising natural extract into a globally accepted, evidence-based cosmeceutical ingredient.

REFERENCES

As published

Showing references and in-text citations exactly as published.

  1. 1.Akihisa, T.; Nakamura, Y.; Tagata, M.; Tokuda, H.; Yasukawa, K.; Uchiyama, E. et al. Anti-inflammatory and anti-tumor-promoting effects of triterpenoids and sterols from Ganoderma lucidum and related species. Chemistry and Biodiversity. 2007;4(2):224–231. https://doi.org/10.1002/cbdv.200790027DOIGOOGLE SCHOLAR
  2. 2.Baby, S.; Johnson, A. J.. Bioactive compounds from Ganoderma lucidum with dermatological relevance. Mycosphere. 2017;8(9):1610–1624. https://doi.org/10.5943/mycosphere/8/9/10DOIGOOGLE SCHOLAR
  3. 3.Baby, S.; Johnson, A. J.. Dermatology-focused review on Ganoderma lucidum. Mycology. 2020;11(4):210–223. https://doi.org/10.1080/21501203.2020.1766726DOIGOOGLE SCHOLAR
  4. 4.Bao, X.; Liu, C.; Fang, J.; Li, X.. Structural features of immunologically active polysaccharides from Ganoderma lucidum. Phytochemistry. 2001;56(7):693–697. https://doi.org/10.1016/S0031-9422(00DOIGOOGLE SCHOLAR
  5. 5.Bishop, K. S.; Ferguson, L. R.. The interaction between epigenetics, nutrition and the development of cancer. Nutrients. 2015;7(2):922–947. https://doi.org/10.3390/nu7020922DOIGOOGLE SCHOLAR
  6. 6.Bishop, K. S.; Kao, C. H. J.; Xu, Y.; Glucina, M. P.; Paterson, R. R. M.; Ferguson, L. R.. From 2000 years of Ganoderma lucidum to recent developments in nutraceuticals. Phytochemistry. 2015;114:56–65. https://doi.org/10.1016/j.phytochem.2015.02.015DOIGOOGLE SCHOLAR
  7. 7.Bishop, K. S.; Lello, J.; Roe, E. et al. Evaluation of the safety of Ganoderma lucidum in human clinical trials. Phytotherapy Research. 2015;29(2):193–200. https://doi.org/10.1002/ptr.5243DOIGOOGLE SCHOLAR
  8. 8.Boh, B.; Berovic, M.; Zhang, J.; Zhi-Bin, L.. Ganoderma lucidum and its pharmaceutically active compounds. Biotechnology Annual Review. 2007;13:265–301. https://doi.org/10.1016/S1387-2656(07DOIGOOGLE SCHOLAR
  9. 9.Chan, W. K.; Law, H. K. W.; Lin, Z.-B.; Lau, Y. L.; Chan, G. C.-F.. Response of human dendritic cells to different immunomodulatory polysaccharides derived from mushroom and barley. International Immunology. 2007;19(7):891–899. https://doi.org/10.1093/intimm/dxm061DOIGOOGLE SCHOLAR
  10. 10.Chen, S.; Oh, S. R.; Phung, S.; Hur, G.; Ye, J. J.; Kwok, S. L.. Anti-oxidant and anti-cancer properties of Ganoderma lucidum. Molecular Carcinogenesis. 2012;51(7):606–614. https://doi.org/10.1002/mc.20833DOIGOOGLE SCHOLAR
  11. 11.Chien, C. M.; Cheng, J. L.; Chang, W. T. et al. Polysaccharides of Ganoderma lucidum alter cell cycle progression and immune responses in human monocytes. International Journal of Oncology. 2004;25(4):841–848. https://doi.org/10.3892/ijo.25.4.841DOIGOOGLE SCHOLAR
  12. 12.Gao, Y.; Zhou, S.; Jiang, W. et al. Antioxidant and tyrosinase inhibitory activities of Ganoderma lucidum extracts: Implications for cosmeceutical use. Journal of Ethnopharmacology. 2003;88(1):25–30. https://doi.org/10.1016/S0378-8741(03DOIGOOGLE SCHOLAR
  13. 13.Guo, X.; Zou, X.; Sun, M. et al. Protective effects of Ganoderma lucidum polysaccharides on UVB-induced skin damage in mice. International Journal of Biological Macromolecules. 2019;133:706–712. https://doi.org/10.1016/j.ijbiomac.2019.04.116DOIGOOGLE SCHOLAR
  14. 14.Hapuarachchi, K. K.; Elkhateeb, W. A.; Karunarathna, S. C. et al. Current status of global Ganoderma research: Taxonomy, diversity, distribution, and culture. Mycosphere. 2018;9(5):1025–1052. https://doi.org/10.5943/mycosphere/9/5/7DOIGOOGLE SCHOLAR
  15. 15.Jiang, J.; Slivova, V.; Sliva, D.. Ganoderma lucidum inhibits proliferation and induces apoptosis in human breast cancer cells. International Journal of Oncology. 2008;33(4):793–798. https://doi.org/10.3892/ijo_00000069DOIGOOGLE SCHOLAR
  16. 16.Joseph, S.; Sabulal, B.; George, V.; Antony, K. R.; Janardhanan, K. K.. Antitumor and anti-inflammatory activities of polysaccharides isolated from Ganoderma lucidum. Acta Pharmaceutica. 2011;61(3):335–342. https://doi.org/10.2478/v10007-011-0030-6DOIGOOGLE SCHOLAR
  17. 17.Juncal-Ruiz, M.; Riesco-Davila, L.; Vazquez-Bourgon, J.; Ortiz-Garcia de la Foz, V.; Mayoral-Van Son, J.; Ayesa-Arriola, R. et al. Ganoderma lucidum extracts attenuate oxidative stress and inflammation in UVB-induced photoaging. International Journal of Molecular Sciences. 2020;21(17):Article 6106. https://doi.org/10.3390/ijms21176106DOIGOOGLE SCHOLAR
  18. 18.Kim, H. S.; Kim, J. Y.; Ryu, H. S. et al. Immunomodulatory activity of beta-glucan from Ganoderma lucidum in human B lymphocytes. International Immunopharmacology. 2012;14(4):512–518. https://doi.org/10.1016/j.intimp.2012.08.014DOIGOOGLE SCHOLAR
  19. 19.Kuo, M. C.; Weng, C. Y.; Ha, C. L.; Wu, M. J.. Prevention of oxidative stress in PC12 cells by Ganoderma lucidum. Phytotherapy Research. 2006;20(12):986–991. https://doi.org/10.1002/ptr.1999DOIGOOGLE SCHOLAR
  20. 20.Lin, S. B.; Li, C. H.; Lee, S. S.; Kan, L. S.. Triterpene-enriched extract from Ganoderma lucidum inhibits growth of hepatoma cells via suppressing protein kinase C and telomerase. Life Sciences. 2003;72(21):2381–2390. https://doi.org/10.1016/S0024-3205(03DOIGOOGLE SCHOLAR
  21. 21.Lin, Z.-B.. Cellular and molecular mechanisms of immuno-modulation by Ganoderma lucidum. Journal of Pharmacological Sciences. 2005;99(2):144–153. https://doi.org/10.1254/jphs.CRJ05008XDOIGOOGLE SCHOLAR
  22. 22.Paterson, R. R.; Lima, N.. Toxicology of Ganoderma lucidum: No evidence of toxicity. Phytochemistry. 2014;114:195–200. https://doi.org/10.1016/j.phytochem.2014.09.005DOIGOOGLE SCHOLAR
  23. 23.Roy, S.; Ghosh, B. D.; Goh, K. L.; Muthoka, R. M.; Kim, J.. Ganoderma lucidum polysaccharides: A review of their role in skin health and dermatological applications. Carbohydrate Polymers. 2022;278:Article 118974. https://doi.org/10.1016/j.carbpol.2021.118974DOIGOOGLE SCHOLAR
  24. 24.Sanodiya, B. S.; Thakur, G. S.; Baghel, R. K.; Prasad, G. B.; Bisen, P. S.. Ganoderma lucidum: A potent pharmacological macrofungus. Current Pharmaceutical Biotechnology. 2009;10(8):717–742. https://doi.org/10.2174/138920109789978757DOIGOOGLE SCHOLAR
  25. 25.Shiao, M.-S.. Natural products of the medicinal fungus Ganoderma lucidum: Occurrence, biological activities, and pharmacological functions. Chemical Record. 2003;3(3):172–180. https://doi.org/10.1002/tcr.10058DOIGOOGLE SCHOLAR
  26. 26.Sliva, D.; Labarrere, C.; Slivova, V.; Sedlak, M.; Lloyd, F. P.; Ho, N. W. Y.. Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells. Biochemical and Biophysical Research Communications. 2002;298(4):603–612. https://doi.org/10.1016/S0006-291X(02DOIGOOGLE SCHOLAR
  27. 27.Sudheer, S.; Gangaprasad, A.. Molecular docking and simulation studies of bioactive compounds from Ganoderma lucidum with reference to anti-aging potential. Journal of Molecular Graphics and Modelling. 2017;73:13–21. https://doi.org/10.1016/j.jmgm.2017.01.008DOIGOOGLE SCHOLAR
  28. 28.Tang, W.; Liu, J. W.; Zhao, W. M.; Wei, D. Z.. Improvement of soluble expression of Ganoderma lucidum immunomodulatory protein by molecular chaperones in Escherichia coli. Applied Microbiology and Biotechnology. 2006;72(3):522–528. https://doi.org/10.1007/s00253-005-0301-yDOIGOOGLE SCHOLAR
  29. 29.Thakur, A.; Sharma, P.; Sanodiya, B. S. et al. Ganoderma lucidum: A potent pharmacological macrofungus. Current Pharmaceutical Biotechnology. 2015;16(7):551–570. https://doi.org/10.2174/1389201016666150812124327DOIGOOGLE SCHOLAR
  30. 30.Wasser, S. P.. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Applied Microbiology and Biotechnology. 2002;60(3):258–274. https://doi.org/10.1007/s00253-002-1076-7DOIGOOGLE SCHOLAR
  31. 31.Wasser, S. P.. Medicinal mushroom science: History, current status, future trends, and unsolved problems. International Journal of Medicinal Mushrooms. 2010;12(1):1–16. https://doi.org/10.1615/IntJMedMushr.v12.i1.10DOIGOOGLE SCHOLAR
  32. 32.Wasser, S. P.. Medicinal mushroom science: Current perspectives, advances, evidences, and challenges. Biomedical Journal. 2014;37(6):345–356. https://doi.org/10.4103/2319-4170.138318DOIGOOGLE SCHOLAR
  33. 33.Xu, J.; He, X.; Bi, Y. et al. Antioxidant and anti-aging activities of polysaccharides from Ganoderma lucidum. International Journal of Biological Macromolecules. 2019;120:811–819. https://doi.org/10.1016/j.ijbiomac.2018.08.139DOIGOOGLE SCHOLAR
  34. 34.Xu, J.; Zhao, W.; Pan, Y. et al. Antioxidant and hepatoprotective effects of Ganoderma lucidum polysaccharides. Food Chemistry. 2011;125(2):749–754. https://doi.org/10.1016/j.foodchem.2010.09.046DOIGOOGLE SCHOLAR
  35. 35.Xu, X. Y.; Jiang, L.; Wu, Y. et al. Antioxidant and anti-inflammatory activities of triterpenoids from Ganoderma lucidum. Food Chemistry. 2010;119(4):1571–1576. https://doi.org/10.1016/j.foodchem.2009.09.050DOIGOOGLE SCHOLAR
  36. 36.Xu, Z.; Chen, X.; Zhong, Z.; Chen, L.; Wang, Y.. Ganoderma lucidum polysaccharides: Immunomodulation and potential applications in skin health. Journal of Cellular and Molecular Medicine. 2011;15(5):1011–1019. https://doi.org/10.1111/j.1582-4934.2010.01091.xDOIGOOGLE SCHOLAR
  37. 37.Yeh, C. H.; Chen, H. C.; Yang, J. J.; Chuang, W. I.; Sheu, J. R.. Ganoderma lucidum polysaccharides modulate platelet activation and protect skin microcirculation. Journal of Ethnopharmacology. 2009;122(1):36–43. https://doi.org/10.1016/j.jep.2008.11.015DOIGOOGLE SCHOLAR
  38. 38.Yue, G. G.; Fung, K. P.; Leung, P. C.; Lau, C. B.. Comparative studies on the immunomodulatory and anti-cancer activities of different Ganoderma lucidum extracts. Journal of Ethnopharmacology. 2013;150(1):568–577. https://doi.org/10.1016/j.jep.2013.09.019DOIGOOGLE SCHOLAR
  39. 39.Yue, G. G.; Fung, K. P.; Tse, G. M. et al. Comparative studies of Ganoderma lucidum extracts and triterpenes on anti-proliferative and pro-apoptotic effects in human carcinoma cells. International Journal of Molecular Medicine. 2008;22(5):597–606.GOOGLE SCHOLAR
  40. 40.Yuen, J. W. M.; Gohel, M. D. I.. Anticancer effects of Ganoderma lucidum: A review of scientific evidence. Nutrition and Cancer. 2005;53(1):11–17. https://doi.org/10.1207/s15327914nc5301_2DOIGOOGLE SCHOLAR
  41. 41.Zhang, W.; Chen, W.; Chen, L. et al. Effects of polysaccharides from Ganoderma lucidum on skin photoaging induced by UV irradiation. Journal of Ethnopharmacology. 2019;236:107–116. https://doi.org/10.1016/j.jep.2019.02.039DOIGOOGLE SCHOLAR
  42. 42.Zhao, S.; Ye, G.; Fu, G.; Cheng, J. X.; Yang, B. B.; Peng, C.. Ganoderma lucidum polysaccharides attenuate UV-induced skin aging via regulation of oxidative stress. Oxidative Medicine and Cellular Longevity. 2019;2019:1–12. https://doi.org/10.1155/2019/3714358DOIGOOGLE SCHOLAR
  43. 43.Zhu, X. L.; Lin, Z. B.. Ganoderma lucidum polysaccharides improve antioxidant enzyme activity in aging mice. Journal of Ethnopharmacology. 2006;103(1):126–134. https://doi.org/10.1016/j.jep.2005.07.012DOIGOOGLE SCHOLAR
  44. 44.Zhu, X.-L.; Chen, A.-F.; Lin, Z.-B.. Ganoderma lucidum polysaccharides enhance immune responses in immunocompromised mice. Journal of Ethnopharmacology. 2007;111(2):219–226. https://doi.org/10.1016/j.jep.2006.11.013DOIGOOGLE SCHOLAR

Cite this article

SELECT FORMAT

Sharma, P. (2026). Therapeutic and Dermatological Potential of Ganoderma lucidum (Reishi/Lingzhi) in Cosmeceutical Formulations: A Comprehensive Review. Journal of Young Pharmacists, 18(3), 646–655. https://doi.org/10.5530/jyp.20260426